Trials / Completed
CompletedNCT00080158
Treatment of Adolescent Suicide Attempters (TASA)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.
Detailed description
Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies. Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluoxetine | |
| DRUG | sertraline | |
| DRUG | citalopram | |
| DRUG | escitalopram | |
| DRUG | bupropion | |
| DRUG | mirtazapine | |
| DRUG | venlafaxine | |
| DRUG | lithium | |
| BEHAVIORAL | Cognitive Behavioral Therapy |
Timeline
- Start date
- 2004-03-01
- Completion
- 2007-06-01
- First posted
- 2004-03-26
- Last updated
- 2020-06-22
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00080158. Inclusion in this directory is not an endorsement.